Oct 25, 2017

Anthem's ACA membership will drop by 70% next year

Anthem's ACA footprint will decline significantly in 2018. Photo: Michael Conroy / AP

Anthem's membership in the Affordable Care Act marketplaces will decline by 70% in 2018, executives told investors Wednesday on the insurer's third-quarter earnings call. About 1.4 million people had ACA-compliant plans with Anthem as of Sept. 30, 900,000 of whom bought coverage on the exchanges.

Between the lines: Anthem, which posted a $747 million third-quarter profit, has announced its ACA exit strategy in many states throughout the year. A 70% drop in ACA customers is steep, and means a lot of people will have to pick a new plan. Anthem is mostly staying in regions where it is the monopoly ACA insurer, which is more likely to ensure profitability.

Go deeper

Snapchat will no longer promote Trump's account in Discover

Photo: Chip Somodevilla/Getty Images

Snapchat will no longer promote President Trump's account on its "Discover" page of curated content, a spokesperson tells Axios, after Trump tweeted comments that some suggested glorified violence amid racial justice protests.

Why it matters: Snapchat is taking action on the president's account for comments he made elsewhere. That's going farther than other big tech firms and signals a commitment to aligning content served to users with core values, rather than making moderation decisions based narrowly on each post made on its own platform.

Updated 1 hour ago - Politics & Policy

Esper catches White House off guard with opposition to military use, photo op

Defense Secretary Mark Esper said at a press briefing Wednesday that he does not currently support invoking the Insurrection Act, an 1807 law that permits the president to use active-duty troops on U.S. soil, in order to quell protests against racial injustice.

Why it matters: President Trump threatened this week to deploy military forces if state and local governments aren't able to squash violent protests. Axios reported on Wednesday that Trump is backing off the idea for now, but that he hasn't ruled it out.

Chinese coronavirus test maker agreed to build a Xinjiang gene bank

Illustration: Annelise Capossela/Axios

A leading Chinese gene sequencing and biomedical firm that said it would build a gene bank in Xinjiang is supplying coronavirus tests around the world.

Why it matters: U.S. officials are worried that widespread coronavirus testing may provide an opportunity for state-connected companies to compile massive DNA databases for research as well as genetics-based surveillance.